Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Non-Current Deferred Tax Liability (2019 - 2020)

Silence Therapeutics' Non-Current Deferred Tax Liability history spans 1 years, with the latest figure at $33011.3 for Q4 2020.

  • For Q4 2020, Non-Current Deferred Tax Liability changed N/A year-over-year to $33011.3; the TTM value through Dec 2020 reached $33011.3, changed N/A, while the annual FY2020 figure was $32103.7, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2020 was $33011.3 at Silence Therapeutics.
  • Across five years, Non-Current Deferred Tax Liability topped out at $33011.3 in Q4 2020 and bottomed at $33011.3 in Q4 2020.